FST and osteoporosis: If FS administration prior to or during radiotherapy proves to be effective in preclinical models, the translation to human studies could be rapid since follistatin is presently being tested as a therapeutic in clinical trials for other disease models, including osteoporosis and muscle wasting disease [67].